When tested for association with HER2 positive status, the following features were confirmed significant at multivariate analysis in the development cohort: tumour grading (analysed as continuous variable), histotype (diffuse versus intestinal) and site of sampling (primary versus metastases). Here, ERBB2 is linked to neoplasm.